nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP2D6—Lomustine—brain cancer	0.137	0.201	CbGbCtD
Cilostazol—CYP1A2—Carmustine—brain cancer	0.136	0.199	CbGbCtD
Cilostazol—CYP2D6—Hydroxyurea—brain cancer	0.104	0.152	CbGbCtD
Cilostazol—CYP3A4—Temozolomide—brain cancer	0.103	0.15	CbGbCtD
Cilostazol—CYP3A4—Lomustine—brain cancer	0.0872	0.128	CbGbCtD
Cilostazol—CYP3A5—Etoposide—brain cancer	0.054	0.0793	CbGbCtD
Cilostazol—CYP1A2—Etoposide—brain cancer	0.0402	0.059	CbGbCtD
Cilostazol—CYP3A4—Etoposide—brain cancer	0.0211	0.0309	CbGbCtD
Cilostazol—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00217	0.0479	CbGpPWpGaD
Cilostazol—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00198	0.0436	CbGpPWpGaD
Cilostazol—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.00187	0.0412	CbGpPWpGaD
Cilostazol—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00169	0.0373	CbGpPWpGaD
Cilostazol—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00168	0.0371	CbGpPWpGaD
Cilostazol—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00155	0.0342	CbGpPWpGaD
Cilostazol—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00154	0.034	CbGpPWpGaD
Cilostazol—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.00135	0.0298	CbGpPWpGaD
Cilostazol—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.0013	0.0286	CbGpPWpGaD
Cilostazol—Epistaxis—Procarbazine—brain cancer	0.00111	0.00406	CcSEcCtD
Cilostazol—Blood creatinine increased—Hydroxyurea—brain cancer	0.00111	0.00405	CcSEcCtD
Cilostazol—Diabetes mellitus—Carmustine—brain cancer	0.0011	0.00402	CcSEcCtD
Cilostazol—Hyperuricaemia—Etoposide—brain cancer	0.0011	0.00402	CcSEcCtD
Cilostazol—Ear pain—Temozolomide—brain cancer	0.00108	0.00396	CcSEcCtD
Cilostazol—Body temperature increased—Carboplatin—brain cancer	0.00107	0.00391	CcSEcCtD
Cilostazol—Haemoglobin—Procarbazine—brain cancer	0.00106	0.00389	CcSEcCtD
Cilostazol—Haemorrhage—Procarbazine—brain cancer	0.00106	0.00387	CcSEcCtD
Cilostazol—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00104	0.023	CbGpPWpGaD
Cilostazol—Gastroenteritis—Temozolomide—brain cancer	0.00104	0.00381	CcSEcCtD
Cilostazol—Blood uric acid increased—Etoposide—brain cancer	0.00104	0.00379	CcSEcCtD
Cilostazol—Vascular purpura—Temozolomide—brain cancer	0.00103	0.00378	CcSEcCtD
Cilostazol—Decreased appetite—Lomustine—brain cancer	0.00103	0.00376	CcSEcCtD
Cilostazol—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.001	0.0221	CbGpPWpGaD
Cilostazol—Hot flush—Temozolomide—brain cancer	0.000987	0.00361	CcSEcCtD
Cilostazol—Menopausal symptoms—Temozolomide—brain cancer	0.000979	0.00358	CcSEcCtD
Cilostazol—Pancytopenia—Hydroxyurea—brain cancer	0.00097	0.00355	CcSEcCtD
Cilostazol—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.00096	0.0212	CbGpPWpGaD
Cilostazol—Purpura—Temozolomide—brain cancer	0.000958	0.00351	CcSEcCtD
Cilostazol—Diplopia—Carmustine—brain cancer	0.000956	0.0035	CcSEcCtD
Cilostazol—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.000956	0.0035	CcSEcCtD
Cilostazol—Chills—Procarbazine—brain cancer	0.000948	0.00347	CcSEcCtD
Cilostazol—Body temperature increased—Lomustine—brain cancer	0.000935	0.00342	CcSEcCtD
Cilostazol—Oesophagitis—Etoposide—brain cancer	0.00093	0.00341	CcSEcCtD
Cilostazol—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000926	0.0204	CbGpPWpGaD
Cilostazol—Diplopia—Temozolomide—brain cancer	0.000924	0.00338	CcSEcCtD
Cilostazol—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000923	0.0204	CbGpPWpGaD
Cilostazol—Face oedema—Carmustine—brain cancer	0.000923	0.00338	CcSEcCtD
Cilostazol—Face oedema—Temozolomide—brain cancer	0.000892	0.00326	CcSEcCtD
Cilostazol—Liver function test abnormal—Carmustine—brain cancer	0.000882	0.00323	CcSEcCtD
Cilostazol—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000862	0.00315	CcSEcCtD
Cilostazol—Anaemia—Procarbazine—brain cancer	0.00085	0.00311	CcSEcCtD
Cilostazol—Dry skin—Temozolomide—brain cancer	0.000847	0.0031	CcSEcCtD
Cilostazol—Syncope—Procarbazine—brain cancer	0.000825	0.00302	CcSEcCtD
Cilostazol—Leukopenia—Procarbazine—brain cancer	0.000823	0.00301	CcSEcCtD
Cilostazol—Haemoglobin—Hydroxyurea—brain cancer	0.000822	0.00301	CcSEcCtD
Cilostazol—Haemorrhage—Hydroxyurea—brain cancer	0.000818	0.00299	CcSEcCtD
Cilostazol—Cardiac failure congestive—Etoposide—brain cancer	0.000815	0.00298	CcSEcCtD
Cilostazol—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000813	0.0179	CbGpPWpGaD
Cilostazol—Loss of consciousness—Procarbazine—brain cancer	0.000809	0.00296	CcSEcCtD
Cilostazol—Cough—Procarbazine—brain cancer	0.000803	0.00294	CcSEcCtD
Cilostazol—Hypertension—Procarbazine—brain cancer	0.000794	0.00291	CcSEcCtD
Cilostazol—Pancytopenia—Carmustine—brain cancer	0.000784	0.00287	CcSEcCtD
Cilostazol—Myalgia—Procarbazine—brain cancer	0.000783	0.00287	CcSEcCtD
Cilostazol—Arthralgia—Procarbazine—brain cancer	0.000783	0.00287	CcSEcCtD
Cilostazol—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000782	0.0172	CbGpPWpGaD
Cilostazol—Anxiety—Procarbazine—brain cancer	0.00078	0.00286	CcSEcCtD
Cilostazol—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000775	0.0171	CbGpPWpGaD
Cilostazol—Bronchitis—Temozolomide—brain cancer	0.000768	0.00281	CcSEcCtD
Cilostazol—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000765	0.0169	CbGpPWpGaD
Cilostazol—Pancytopenia—Temozolomide—brain cancer	0.000758	0.00277	CcSEcCtD
Cilostazol—Cardiac failure—Etoposide—brain cancer	0.000757	0.00277	CcSEcCtD
Cilostazol—Vomiting—Lomustine—brain cancer	0.000752	0.00275	CcSEcCtD
Cilostazol—Oedema—Procarbazine—brain cancer	0.000751	0.00275	CcSEcCtD
Cilostazol—Infection—Procarbazine—brain cancer	0.000746	0.00273	CcSEcCtD
Cilostazol—Angiopathy—Hydroxyurea—brain cancer	0.000742	0.00272	CcSEcCtD
Cilostazol—Pneumonia—Carmustine—brain cancer	0.000741	0.00271	CcSEcCtD
Cilostazol—PDE3A—Platelet homeostasis—TRPC6—brain cancer	0.000739	0.0163	CbGpPWpGaD
Cilostazol—Shock—Procarbazine—brain cancer	0.000739	0.0027	CcSEcCtD
Cilostazol—Pollakiuria—Temozolomide—brain cancer	0.000737	0.0027	CcSEcCtD
Cilostazol—Thrombocytopenia—Procarbazine—brain cancer	0.000735	0.00269	CcSEcCtD
Cilostazol—Chills—Hydroxyurea—brain cancer	0.000734	0.00269	CcSEcCtD
Cilostazol—Tachycardia—Procarbazine—brain cancer	0.000733	0.00268	CcSEcCtD
Cilostazol—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000716	0.0158	CbGpPWpGaD
Cilostazol—Urinary tract infection—Carmustine—brain cancer	0.000716	0.00262	CcSEcCtD
Cilostazol—Pneumonia—Temozolomide—brain cancer	0.000716	0.00262	CcSEcCtD
Cilostazol—Anorexia—Procarbazine—brain cancer	0.000716	0.00262	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000706	0.00258	CcSEcCtD
Cilostazol—Cardiac arrest—Etoposide—brain cancer	0.000703	0.00257	CcSEcCtD
Cilostazol—Nausea—Lomustine—brain cancer	0.000702	0.00257	CcSEcCtD
Cilostazol—Hypotension—Procarbazine—brain cancer	0.000702	0.00257	CcSEcCtD
Cilostazol—Urinary tract infection—Temozolomide—brain cancer	0.000692	0.00253	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000684	0.0025	CcSEcCtD
Cilostazol—Insomnia—Procarbazine—brain cancer	0.000679	0.00249	CcSEcCtD
Cilostazol—Paraesthesia—Procarbazine—brain cancer	0.000674	0.00247	CcSEcCtD
Cilostazol—Hepatobiliary disease—Temozolomide—brain cancer	0.000673	0.00246	CcSEcCtD
Cilostazol—Sinusitis—Temozolomide—brain cancer	0.000668	0.00244	CcSEcCtD
Cilostazol—Haemoglobin—Carmustine—brain cancer	0.000665	0.00243	CcSEcCtD
Cilostazol—Haemorrhage—Carmustine—brain cancer	0.000661	0.00242	CcSEcCtD
Cilostazol—Ill-defined disorder—Hydroxyurea—brain cancer	0.000661	0.00242	CcSEcCtD
Cilostazol—Anaemia—Hydroxyurea—brain cancer	0.000658	0.00241	CcSEcCtD
Cilostazol—Hypoaesthesia—Carmustine—brain cancer	0.000658	0.00241	CcSEcCtD
Cilostazol—Decreased appetite—Procarbazine—brain cancer	0.000653	0.00239	CcSEcCtD
Cilostazol—Oedema peripheral—Carmustine—brain cancer	0.000651	0.00238	CcSEcCtD
Cilostazol—Haemoglobin—Temozolomide—brain cancer	0.000642	0.00235	CcSEcCtD
Cilostazol—Malaise—Hydroxyurea—brain cancer	0.000642	0.00235	CcSEcCtD
Cilostazol—Pain—Procarbazine—brain cancer	0.000642	0.00235	CcSEcCtD
Cilostazol—Haemorrhage—Temozolomide—brain cancer	0.000639	0.00234	CcSEcCtD
Cilostazol—Leukopenia—Hydroxyurea—brain cancer	0.000637	0.00233	CcSEcCtD
Cilostazol—Hypoaesthesia—Temozolomide—brain cancer	0.000636	0.00233	CcSEcCtD
Cilostazol—Pharyngitis—Temozolomide—brain cancer	0.000634	0.00232	CcSEcCtD
Cilostazol—Oedema peripheral—Temozolomide—brain cancer	0.000629	0.0023	CcSEcCtD
Cilostazol—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000628	0.0139	CbGpPWpGaD
Cilostazol—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000627	0.0138	CbGpPWpGaD
Cilostazol—Feeling abnormal—Procarbazine—brain cancer	0.000619	0.00226	CcSEcCtD
Cilostazol—Gastrointestinal pain—Procarbazine—brain cancer	0.000614	0.00225	CcSEcCtD
Cilostazol—Pancytopenia—Etoposide—brain cancer	0.000607	0.00222	CcSEcCtD
Cilostazol—Erythema multiforme—Temozolomide—brain cancer	0.000604	0.00221	CcSEcCtD
Cilostazol—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000603	0.0133	CbGpPWpGaD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000602	0.0022	CcSEcCtD
Cilostazol—Discomfort—Hydroxyurea—brain cancer	0.000599	0.00219	CcSEcCtD
Cilostazol—Urticaria—Procarbazine—brain cancer	0.000596	0.00218	CcSEcCtD
Cilostazol—Tinnitus—Temozolomide—brain cancer	0.000596	0.00218	CcSEcCtD
Cilostazol—Body temperature increased—Procarbazine—brain cancer	0.000594	0.00217	CcSEcCtD
Cilostazol—Abdominal pain—Procarbazine—brain cancer	0.000594	0.00217	CcSEcCtD
Cilostazol—Cardiac disorder—Temozolomide—brain cancer	0.000593	0.00217	CcSEcCtD
Cilostazol—Oedema—Hydroxyurea—brain cancer	0.000581	0.00213	CcSEcCtD
Cilostazol—Angiopathy—Temozolomide—brain cancer	0.00058	0.00212	CcSEcCtD
Cilostazol—Infection—Hydroxyurea—brain cancer	0.000577	0.00211	CcSEcCtD
Cilostazol—Mediastinal disorder—Temozolomide—brain cancer	0.000576	0.00211	CcSEcCtD
Cilostazol—Chills—Temozolomide—brain cancer	0.000573	0.0021	CcSEcCtD
Cilostazol—Pneumonia—Etoposide—brain cancer	0.000573	0.0021	CcSEcCtD
Cilostazol—Nervous system disorder—Hydroxyurea—brain cancer	0.00057	0.00209	CcSEcCtD
Cilostazol—Thrombocytopenia—Hydroxyurea—brain cancer	0.000569	0.00208	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000565	0.00207	CcSEcCtD
Cilostazol—Skin disorder—Hydroxyurea—brain cancer	0.000564	0.00207	CcSEcCtD
Cilostazol—Acute coronary syndrome—Etoposide—brain cancer	0.000561	0.00205	CcSEcCtD
Cilostazol—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00056	0.0124	CbGpPWpGaD
Cilostazol—Myocardial infarction—Etoposide—brain cancer	0.000558	0.00204	CcSEcCtD
Cilostazol—Back pain—Carmustine—brain cancer	0.000557	0.00204	CcSEcCtD
Cilostazol—Jaundice—Etoposide—brain cancer	0.000555	0.00203	CcSEcCtD
Cilostazol—Anorexia—Hydroxyurea—brain cancer	0.000554	0.00203	CcSEcCtD
Cilostazol—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000553	0.0122	CbGpPWpGaD
Cilostazol—Asthenia—Procarbazine—brain cancer	0.000539	0.00197	CcSEcCtD
Cilostazol—Hepatobiliary disease—Etoposide—brain cancer	0.000539	0.00197	CcSEcCtD
Cilostazol—Back pain—Temozolomide—brain cancer	0.000538	0.00197	CcSEcCtD
Cilostazol—Anaemia—Carmustine—brain cancer	0.000532	0.00195	CcSEcCtD
Cilostazol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000532	0.0117	CbGpPWpGaD
Cilostazol—Agranulocytosis—Etoposide—brain cancer	0.000531	0.00195	CcSEcCtD
Cilostazol—Pruritus—Procarbazine—brain cancer	0.000531	0.00194	CcSEcCtD
Cilostazol—Dyspnoea—Hydroxyurea—brain cancer	0.000518	0.0019	CcSEcCtD
Cilostazol—Ill-defined disorder—Temozolomide—brain cancer	0.000516	0.00189	CcSEcCtD
Cilostazol—Leukopenia—Carmustine—brain cancer	0.000515	0.00189	CcSEcCtD
Cilostazol—Anaemia—Temozolomide—brain cancer	0.000514	0.00188	CcSEcCtD
Cilostazol—Diarrhoea—Procarbazine—brain cancer	0.000514	0.00188	CcSEcCtD
Cilostazol—Dyspepsia—Hydroxyurea—brain cancer	0.000511	0.00187	CcSEcCtD
Cilostazol—Hypoaesthesia—Etoposide—brain cancer	0.000509	0.00186	CcSEcCtD
Cilostazol—Decreased appetite—Hydroxyurea—brain cancer	0.000505	0.00185	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000502	0.00184	CcSEcCtD
Cilostazol—Malaise—Temozolomide—brain cancer	0.000502	0.00184	CcSEcCtD
Cilostazol—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000501	0.0111	CbGpPWpGaD
Cilostazol—Vertigo—Temozolomide—brain cancer	0.0005	0.00183	CcSEcCtD
Cilostazol—Leukopenia—Temozolomide—brain cancer	0.000498	0.00182	CcSEcCtD
Cilostazol—Hypertension—Carmustine—brain cancer	0.000497	0.00182	CcSEcCtD
Cilostazol—Pain—Hydroxyurea—brain cancer	0.000497	0.00182	CcSEcCtD
Cilostazol—Dizziness—Procarbazine—brain cancer	0.000496	0.00182	CcSEcCtD
Cilostazol—Palpitations—Temozolomide—brain cancer	0.000492	0.0018	CcSEcCtD
Cilostazol—Myalgia—Carmustine—brain cancer	0.00049	0.00179	CcSEcCtD
Cilostazol—Chest pain—Carmustine—brain cancer	0.00049	0.00179	CcSEcCtD
Cilostazol—Anxiety—Carmustine—brain cancer	0.000488	0.00179	CcSEcCtD
Cilostazol—Cough—Temozolomide—brain cancer	0.000485	0.00178	CcSEcCtD
Cilostazol—Erythema multiforme—Etoposide—brain cancer	0.000483	0.00177	CcSEcCtD
Cilostazol—Hypertension—Temozolomide—brain cancer	0.00048	0.00176	CcSEcCtD
Cilostazol—Feeling abnormal—Hydroxyurea—brain cancer	0.000479	0.00175	CcSEcCtD
Cilostazol—Vomiting—Procarbazine—brain cancer	0.000477	0.00175	CcSEcCtD
Cilostazol—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000476	0.0105	CbGpPWpGaD
Cilostazol—Cardiac disorder—Etoposide—brain cancer	0.000474	0.00174	CcSEcCtD
Cilostazol—Arthralgia—Temozolomide—brain cancer	0.000474	0.00173	CcSEcCtD
Cilostazol—Myalgia—Temozolomide—brain cancer	0.000474	0.00173	CcSEcCtD
Cilostazol—Rash—Procarbazine—brain cancer	0.000473	0.00173	CcSEcCtD
Cilostazol—Dermatitis—Procarbazine—brain cancer	0.000473	0.00173	CcSEcCtD
Cilostazol—Anxiety—Temozolomide—brain cancer	0.000472	0.00173	CcSEcCtD
Cilostazol—Headache—Procarbazine—brain cancer	0.00047	0.00172	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00047	0.00172	CcSEcCtD
Cilostazol—Oedema—Carmustine—brain cancer	0.00047	0.00172	CcSEcCtD
Cilostazol—Discomfort—Temozolomide—brain cancer	0.000468	0.00171	CcSEcCtD
Cilostazol—Infection—Carmustine—brain cancer	0.000467	0.00171	CcSEcCtD
Cilostazol—Angiopathy—Etoposide—brain cancer	0.000464	0.0017	CcSEcCtD
Cilostazol—Mediastinal disorder—Etoposide—brain cancer	0.000461	0.00169	CcSEcCtD
Cilostazol—Thrombocytopenia—Carmustine—brain cancer	0.00046	0.00168	CcSEcCtD
Cilostazol—Body temperature increased—Hydroxyurea—brain cancer	0.000459	0.00168	CcSEcCtD
Cilostazol—Chills—Etoposide—brain cancer	0.000459	0.00168	CcSEcCtD
Cilostazol—Tachycardia—Carmustine—brain cancer	0.000458	0.00168	CcSEcCtD
Cilostazol—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000454	0.01	CbGpPWpGaD
Cilostazol—Oedema—Temozolomide—brain cancer	0.000454	0.00166	CcSEcCtD
Cilostazol—Infection—Temozolomide—brain cancer	0.000451	0.00165	CcSEcCtD
Cilostazol—Anorexia—Carmustine—brain cancer	0.000448	0.00164	CcSEcCtD
Cilostazol—Nausea—Procarbazine—brain cancer	0.000446	0.00163	CcSEcCtD
Cilostazol—Nervous system disorder—Temozolomide—brain cancer	0.000445	0.00163	CcSEcCtD
Cilostazol—Thrombocytopenia—Temozolomide—brain cancer	0.000444	0.00163	CcSEcCtD
Cilostazol—Skin disorder—Temozolomide—brain cancer	0.000441	0.00161	CcSEcCtD
Cilostazol—Hypotension—Carmustine—brain cancer	0.000439	0.00161	CcSEcCtD
Cilostazol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000433	0.00956	CbGpPWpGaD
Cilostazol—Anorexia—Temozolomide—brain cancer	0.000433	0.00158	CcSEcCtD
Cilostazol—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000431	0.0095	CbGpPWpGaD
Cilostazol—Back pain—Etoposide—brain cancer	0.000431	0.00158	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Carmustine—brain cancer	0.000428	0.00157	CcSEcCtD
Cilostazol—Muscle spasms—Etoposide—brain cancer	0.000428	0.00157	CcSEcCtD
Cilostazol—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000428	0.00943	CbGpPWpGaD
Cilostazol—Insomnia—Carmustine—brain cancer	0.000425	0.00156	CcSEcCtD
Cilostazol—Paraesthesia—Carmustine—brain cancer	0.000422	0.00154	CcSEcCtD
Cilostazol—Dyspnoea—Carmustine—brain cancer	0.000419	0.00153	CcSEcCtD
Cilostazol—Asthenia—Hydroxyurea—brain cancer	0.000417	0.00153	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000414	0.00151	CcSEcCtD
Cilostazol—Ill-defined disorder—Etoposide—brain cancer	0.000413	0.00151	CcSEcCtD
Cilostazol—Anaemia—Etoposide—brain cancer	0.000411	0.00151	CcSEcCtD
Cilostazol—Insomnia—Temozolomide—brain cancer	0.000411	0.0015	CcSEcCtD
Cilostazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00041	0.00905	CbGpPWpGaD
Cilostazol—Decreased appetite—Carmustine—brain cancer	0.000408	0.00149	CcSEcCtD
Cilostazol—Paraesthesia—Temozolomide—brain cancer	0.000408	0.00149	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Carmustine—brain cancer	0.000406	0.00148	CcSEcCtD
Cilostazol—Dyspnoea—Temozolomide—brain cancer	0.000405	0.00148	CcSEcCtD
Cilostazol—Pain—Carmustine—brain cancer	0.000402	0.00147	CcSEcCtD
Cilostazol—Malaise—Etoposide—brain cancer	0.000401	0.00147	CcSEcCtD
Cilostazol—Vertigo—Etoposide—brain cancer	0.0004	0.00146	CcSEcCtD
Cilostazol—Dyspepsia—Temozolomide—brain cancer	0.0004	0.00146	CcSEcCtD
Cilostazol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000398	0.00879	CbGpPWpGaD
Cilostazol—Leukopenia—Etoposide—brain cancer	0.000398	0.00146	CcSEcCtD
Cilostazol—Diarrhoea—Hydroxyurea—brain cancer	0.000398	0.00146	CcSEcCtD
Cilostazol—Decreased appetite—Temozolomide—brain cancer	0.000395	0.00144	CcSEcCtD
Cilostazol—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000393	0.00868	CbGpPWpGaD
Cilostazol—Gastrointestinal disorder—Temozolomide—brain cancer	0.000392	0.00143	CcSEcCtD
Cilostazol—Loss of consciousness—Etoposide—brain cancer	0.000391	0.00143	CcSEcCtD
Cilostazol—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000391	0.00862	CbGpPWpGaD
Cilostazol—Cough—Etoposide—brain cancer	0.000388	0.00142	CcSEcCtD
Cilostazol—Pain—Temozolomide—brain cancer	0.000388	0.00142	CcSEcCtD
Cilostazol—Feeling abnormal—Carmustine—brain cancer	0.000387	0.00142	CcSEcCtD
Cilostazol—Hypertension—Etoposide—brain cancer	0.000384	0.00141	CcSEcCtD
Cilostazol—Dizziness—Hydroxyurea—brain cancer	0.000384	0.00141	CcSEcCtD
Cilostazol—Gastrointestinal pain—Carmustine—brain cancer	0.000384	0.00141	CcSEcCtD
Cilostazol—Chest pain—Etoposide—brain cancer	0.000379	0.00139	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000376	0.00138	CcSEcCtD
Cilostazol—Discomfort—Etoposide—brain cancer	0.000374	0.00137	CcSEcCtD
Cilostazol—PDE3A—Hemostasis—MPL—brain cancer	0.000374	0.00825	CbGpPWpGaD
Cilostazol—Feeling abnormal—Temozolomide—brain cancer	0.000374	0.00137	CcSEcCtD
Cilostazol—Abdominal pain—Carmustine—brain cancer	0.000371	0.00136	CcSEcCtD
Cilostazol—Body temperature increased—Carmustine—brain cancer	0.000371	0.00136	CcSEcCtD
Cilostazol—Gastrointestinal pain—Temozolomide—brain cancer	0.000371	0.00136	CcSEcCtD
Cilostazol—Vomiting—Hydroxyurea—brain cancer	0.000369	0.00135	CcSEcCtD
Cilostazol—Rash—Hydroxyurea—brain cancer	0.000366	0.00134	CcSEcCtD
Cilostazol—Dermatitis—Hydroxyurea—brain cancer	0.000366	0.00134	CcSEcCtD
Cilostazol—Headache—Hydroxyurea—brain cancer	0.000364	0.00133	CcSEcCtD
Cilostazol—Infection—Etoposide—brain cancer	0.000361	0.00132	CcSEcCtD
Cilostazol—Urticaria—Temozolomide—brain cancer	0.000361	0.00132	CcSEcCtD
Cilostazol—Body temperature increased—Temozolomide—brain cancer	0.000359	0.00131	CcSEcCtD
Cilostazol—Abdominal pain—Temozolomide—brain cancer	0.000359	0.00131	CcSEcCtD
Cilostazol—PDE3A—Hemostasis—S100A10—brain cancer	0.000359	0.00791	CbGpPWpGaD
Cilostazol—Thrombocytopenia—Etoposide—brain cancer	0.000356	0.0013	CcSEcCtD
Cilostazol—Tachycardia—Etoposide—brain cancer	0.000355	0.0013	CcSEcCtD
Cilostazol—Skin disorder—Etoposide—brain cancer	0.000353	0.00129	CcSEcCtD
Cilostazol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000351	0.00775	CbGpPWpGaD
Cilostazol—Anorexia—Etoposide—brain cancer	0.000346	0.00127	CcSEcCtD
Cilostazol—Nausea—Hydroxyurea—brain cancer	0.000345	0.00126	CcSEcCtD
Cilostazol—Hypotension—Etoposide—brain cancer	0.000339	0.00124	CcSEcCtD
Cilostazol—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000338	0.00745	CbGpPWpGaD
Cilostazol—Asthenia—Carmustine—brain cancer	0.000337	0.00123	CcSEcCtD
Cilostazol—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000334	0.00736	CbGpPWpGaD
Cilostazol—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000333	0.00735	CbGpPWpGaD
Cilostazol—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000329	0.00726	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—OR4C12—brain cancer	0.000327	0.00722	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—OR14C36—brain cancer	0.000327	0.00722	CbGpPWpGaD
Cilostazol—Paraesthesia—Etoposide—brain cancer	0.000326	0.00119	CcSEcCtD
Cilostazol—Asthenia—Temozolomide—brain cancer	0.000326	0.00119	CcSEcCtD
Cilostazol—Dyspnoea—Etoposide—brain cancer	0.000324	0.00119	CcSEcCtD
Cilostazol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000323	0.00713	CbGpPWpGaD
Cilostazol—Diarrhoea—Carmustine—brain cancer	0.000321	0.00118	CcSEcCtD
Cilostazol—Pruritus—Temozolomide—brain cancer	0.000321	0.00118	CcSEcCtD
Cilostazol—Decreased appetite—Etoposide—brain cancer	0.000316	0.00116	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Etoposide—brain cancer	0.000314	0.00115	CcSEcCtD
Cilostazol—Dizziness—Carmustine—brain cancer	0.000311	0.00114	CcSEcCtD
Cilostazol—Pain—Etoposide—brain cancer	0.000311	0.00114	CcSEcCtD
Cilostazol—Diarrhoea—Temozolomide—brain cancer	0.000311	0.00114	CcSEcCtD
Cilostazol—Dizziness—Temozolomide—brain cancer	0.0003	0.0011	CcSEcCtD
Cilostazol—Feeling abnormal—Etoposide—brain cancer	0.000299	0.0011	CcSEcCtD
Cilostazol—Vomiting—Carmustine—brain cancer	0.000299	0.00109	CcSEcCtD
Cilostazol—Gastrointestinal pain—Etoposide—brain cancer	0.000297	0.00109	CcSEcCtD
Cilostazol—PDE3A—Signaling by GPCR—OR4C12—brain cancer	0.000297	0.00655	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—OR14C36—brain cancer	0.000297	0.00655	CbGpPWpGaD
Cilostazol—Rash—Carmustine—brain cancer	0.000296	0.00108	CcSEcCtD
Cilostazol—Dermatitis—Carmustine—brain cancer	0.000296	0.00108	CcSEcCtD
Cilostazol—Headache—Carmustine—brain cancer	0.000294	0.00108	CcSEcCtD
Cilostazol—Vomiting—Temozolomide—brain cancer	0.000289	0.00106	CcSEcCtD
Cilostazol—Urticaria—Etoposide—brain cancer	0.000289	0.00106	CcSEcCtD
Cilostazol—Body temperature increased—Etoposide—brain cancer	0.000287	0.00105	CcSEcCtD
Cilostazol—Abdominal pain—Etoposide—brain cancer	0.000287	0.00105	CcSEcCtD
Cilostazol—Rash—Temozolomide—brain cancer	0.000286	0.00105	CcSEcCtD
Cilostazol—Dermatitis—Temozolomide—brain cancer	0.000286	0.00105	CcSEcCtD
Cilostazol—Headache—Temozolomide—brain cancer	0.000284	0.00104	CcSEcCtD
Cilostazol—Nausea—Carmustine—brain cancer	0.000279	0.00102	CcSEcCtD
Cilostazol—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000274	0.00604	CbGpPWpGaD
Cilostazol—Nausea—Temozolomide—brain cancer	0.00027	0.000987	CcSEcCtD
Cilostazol—Asthenia—Etoposide—brain cancer	0.000261	0.000954	CcSEcCtD
Cilostazol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00026	0.00575	CbGpPWpGaD
Cilostazol—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000257	0.00567	CbGpPWpGaD
Cilostazol—Pruritus—Etoposide—brain cancer	0.000257	0.000941	CcSEcCtD
Cilostazol—PDE3A—Hemostasis—BSG—brain cancer	0.000253	0.00558	CbGpPWpGaD
Cilostazol—Diarrhoea—Etoposide—brain cancer	0.000249	0.00091	CcSEcCtD
Cilostazol—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000241	0.00532	CbGpPWpGaD
Cilostazol—Dizziness—Etoposide—brain cancer	0.00024	0.000879	CcSEcCtD
Cilostazol—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000238	0.00525	CbGpPWpGaD
Cilostazol—Vomiting—Etoposide—brain cancer	0.000231	0.000845	CcSEcCtD
Cilostazol—Rash—Etoposide—brain cancer	0.000229	0.000838	CcSEcCtD
Cilostazol—Dermatitis—Etoposide—brain cancer	0.000229	0.000838	CcSEcCtD
Cilostazol—Headache—Etoposide—brain cancer	0.000228	0.000833	CcSEcCtD
Cilostazol—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000221	0.00488	CbGpPWpGaD
Cilostazol—Nausea—Etoposide—brain cancer	0.000216	0.00079	CcSEcCtD
Cilostazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000211	0.00466	CbGpPWpGaD
Cilostazol—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000196	0.00433	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PTCH2—brain cancer	0.000191	0.00422	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000187	0.00412	CbGpPWpGaD
Cilostazol—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000184	0.00406	CbGpPWpGaD
Cilostazol—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.00018	0.00397	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—OR4C12—brain cancer	0.000175	0.00387	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—OR14C36—brain cancer	0.000175	0.00387	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000172	0.00379	CbGpPWpGaD
Cilostazol—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000169	0.00373	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—TRPC6—brain cancer	0.000166	0.00365	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—ABR—brain cancer	0.000165	0.00365	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—ABR—brain cancer	0.00015	0.00331	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00015	0.00331	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—DTX2—brain cancer	0.000149	0.00329	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000145	0.00321	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000143	0.00316	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—VAV1—brain cancer	0.000124	0.00274	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PTCH2—brain cancer	0.000113	0.00249	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000112	0.00247	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000111	0.00244	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HES5—brain cancer	0.000109	0.00242	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—STRADA—brain cancer	0.000106	0.00235	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—TRPC6—brain cancer	0.000105	0.00231	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—SHH—brain cancer	9.86e-05	0.00218	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—TRPC6—brain cancer	9.51e-05	0.0021	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—SMO—brain cancer	9.35e-05	0.00206	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PTCH1—brain cancer	9.35e-05	0.00206	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ABR—brain cancer	8.87e-05	0.00196	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	8.65e-05	0.00191	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—GLI2—brain cancer	8.57e-05	0.00189	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—GLI1—brain cancer	8.06e-05	0.00178	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—PIK3CG—brain cancer	7.88e-05	0.00174	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—VAV1—brain cancer	7.84e-05	0.00173	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	7.79e-05	0.00172	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SUFU—brain cancer	7.64e-05	0.00168	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—GFAP—brain cancer	7.37e-05	0.00163	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.16e-05	0.00158	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—VAV1—brain cancer	7.12e-05	0.00157	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HEY1—brain cancer	6.98e-05	0.00154	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—DLL1—brain cancer	6.85e-05	0.00151	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	6.62e-05	0.00146	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	6.09e-05	0.00134	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	5.96e-05	0.00131	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	5.96e-05	0.00131	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SHH—brain cancer	5.82e-05	0.00128	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP2C9—brain cancer	5.71e-05	0.00126	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TRPC6—brain cancer	5.62e-05	0.00124	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.58e-05	0.00123	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—IL2—brain cancer	5.55e-05	0.00122	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SMO—brain cancer	5.52e-05	0.00122	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PTCH1—brain cancer	5.52e-05	0.00122	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.24e-05	0.00116	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—PIK3CG—brain cancer	4.98e-05	0.0011	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—BSG—brain cancer	4.85e-05	0.00107	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—VEGFA—brain cancer	4.71e-05	0.00104	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PIK3CG—brain cancer	4.52e-05	0.000998	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NOTCH2—brain cancer	4.41e-05	0.000974	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—VAV1—brain cancer	4.21e-05	0.000928	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—IDH1—brain cancer	4.17e-05	0.000921	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP2C9—brain cancer	4.13e-05	0.00091	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.08e-05	0.0009	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HES1—brain cancer	3.62e-05	0.000798	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—TP53—brain cancer	3.56e-05	0.000786	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—BSG—brain cancer	3.51e-05	0.000774	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—IL2—brain cancer	3.5e-05	0.000773	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PDGFRA—brain cancer	3.45e-05	0.00076	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SPP1—brain cancer	3.35e-05	0.000738	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ENO2—brain cancer	3.3e-05	0.000728	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP2C9—brain cancer	3.19e-05	0.000704	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—IL2—brain cancer	3.18e-05	0.000702	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IRS2—brain cancer	3.03e-05	0.000667	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—IDH1—brain cancer	3.02e-05	0.000666	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP2C9—brain cancer	2.93e-05	0.000647	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—BSG—brain cancer	2.71e-05	0.000598	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—APC—brain cancer	2.67e-05	0.000589	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CG—brain cancer	2.67e-05	0.000589	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—BSG—brain cancer	2.49e-05	0.00055	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2C9—brain cancer	2.49e-05	0.000548	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—EGFR—brain cancer	2.43e-05	0.000537	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ENO2—brain cancer	2.38e-05	0.000526	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—IDH1—brain cancer	2.33e-05	0.000515	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—IDH1—brain cancer	2.15e-05	0.000473	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—BSG—brain cancer	2.11e-05	0.000466	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—RELA—brain cancer	2.09e-05	0.000461	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ERBB2—brain cancer	2.07e-05	0.000458	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2C9—brain cancer	1.92e-05	0.000423	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.9e-05	0.000419	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL2—brain cancer	1.88e-05	0.000415	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ENO2—brain cancer	1.84e-05	0.000407	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CCND1—brain cancer	1.83e-05	0.000404	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—IDH1—brain cancer	1.82e-05	0.000401	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CTNNB1—brain cancer	1.81e-05	0.0004	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ENO2—brain cancer	1.7e-05	0.000374	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—BSG—brain cancer	1.63e-05	0.00036	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—VEGFA—brain cancer	1.6e-05	0.000353	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—STAT3—brain cancer	1.58e-05	0.000349	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CG—brain cancer	1.51e-05	0.000334	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.48e-05	0.000327	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MYC—brain cancer	1.47e-05	0.000324	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EGFR—brain cancer	1.44e-05	0.000317	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ENO2—brain cancer	1.44e-05	0.000317	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—IDH1—brain cancer	1.4e-05	0.000309	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TP53—brain cancer	1.21e-05	0.000266	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ENO2—brain cancer	1.11e-05	0.000245	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CG—brain cancer	1.09e-05	0.000241	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CG—brain cancer	8.46e-06	0.000187	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CG—brain cancer	7.78e-06	0.000172	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CG—brain cancer	6.59e-06	0.000145	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CG—brain cancer	5.09e-06	0.000112	CbGpPWpGaD
